Personal tools

MCL coexpression mm9:2024: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001016!2.47e-22!75;UBERON:0001017!5.22e-21!73;UBERON:0004121!9.89e-19!95;UBERON:0000924!9.89e-19!95;UBERON:0006601!9.89e-19!95;UBERON:0000073!2.69e-15!54;UBERON:0002346!6.45e-13!64;UBERON:0003075!6.45e-13!64;UBERON:0007284!6.45e-13!64;UBERON:0002020!1.39e-12!34;UBERON:0001049!4.74e-12!52;UBERON:0005068!4.74e-12!52;UBERON:0006241!4.74e-12!52;UBERON:0007135!4.74e-12!52;UBERON:0010371!6.77e-12!73;UBERON:0010314!1.03e-08!92;UBERON:0002616!3.41e-08!46;UBERON:0001948!4.53e-08!5;UBERON:0002315!4.53e-08!5;UBERON:0002420!6.67e-08!8;UBERON:0007245!6.67e-08!8;UBERON:0010009!6.67e-08!8;UBERON:0010011!6.67e-08!8;UBERON:0000454!6.67e-08!8;UBERON:0000955!6.94e-08!47;UBERON:0006238!6.94e-08!47;UBERON:0000010!8.64e-08!11;UBERON:0003528!8.93e-08!29;UBERON:0002791!8.93e-08!29;UBERON:0001893!8.93e-08!29;UBERON:0003080!1.08e-07!40;UBERON:0002780!4.15e-07!39;UBERON:0001890!4.15e-07!39;UBERON:0006240!4.15e-07!39
|ontology_enrichment_uberon=UBERON:0001016!2.47e-22!75;UBERON:0001017!5.22e-21!73;UBERON:0004121!9.89e-19!95;UBERON:0000924!9.89e-19!95;UBERON:0006601!9.89e-19!95;UBERON:0000073!2.69e-15!54;UBERON:0002346!6.45e-13!64;UBERON:0003075!6.45e-13!64;UBERON:0007284!6.45e-13!64;UBERON:0002020!1.39e-12!34;UBERON:0001049!4.74e-12!52;UBERON:0005068!4.74e-12!52;UBERON:0006241!4.74e-12!52;UBERON:0007135!4.74e-12!52;UBERON:0010371!6.77e-12!73;UBERON:0010314!1.03e-08!92;UBERON:0002616!3.41e-08!46;UBERON:0001948!4.53e-08!5;UBERON:0002315!4.53e-08!5;UBERON:0002420!6.67e-08!8;UBERON:0007245!6.67e-08!8;UBERON:0010009!6.67e-08!8;UBERON:0010011!6.67e-08!8;UBERON:0000454!6.67e-08!8;UBERON:0000955!6.94e-08!47;UBERON:0006238!6.94e-08!47;UBERON:0000010!8.64e-08!11;UBERON:0003528!8.93e-08!29;UBERON:0002791!8.93e-08!29;UBERON:0001893!8.93e-08!29;UBERON:0003080!1.08e-07!40;UBERON:0002780!4.15e-07!39;UBERON:0001890!4.15e-07!39;UBERON:0006240!4.15e-07!39
|tfbs_overrepresentation_for_novel_motifs=0.641384,0.128156,0.612053,0.688265,0.483253,0.704257,0.803568,0.370124,0.381467,0.162942,0.755749,0.790506,0.37041,0.81685,0.502646,0,1.02248,0.473993,0.352304,0.24402,0.570433,0.197567,0.815872,0.481455,0.620553,0.846564,0.342316,0.727368,0.535752,0.290745,0.711848,1.12823,0.471365,0.318879,0.503207,0.089443,0.460474,0.786577,0.434783,0.40068,0.478558,0.717547,0.544696,0.504971,0.0986756,0.675898,0.938241,0.744678,0.162985,0.539131,1.0041,0.875451,0.771943,1.2746,1.29252,0.82458,0.549352,0.776619,0.882473,0.822375,1.10737,0.885556,0.39557,0.992216,0.8366,1.03484,1.43193,1.78579,1.1025,1.63712,0.590754,0.377213,0.205546,1.32691,0.323563,0.310084,0.318792,0.926147,1.08947,0.575233,0.37865,1.04072,0.884013,0.362446,1.20828,0.11855,0.40635,0.290918,0.943446,1.94914,1.50286,1.21342,1.14153,0.490141,0.430015,0.409166,0.367176,1.14445,0.938512,0.264911,0.460566,1.12793,1.25667,1.00472,1.00361,0.717061,1.06633,0.740267,0.580757,0.57247,0.633483,1.25851,0.576517,0.7614,1.51002,0.476467,0.143825,0.692434,1.02384,0.456123,1.33244,2.22508,0.848526,0.925183,1.56496,1.09333,0.812403,1.13449,1.43038,0.493609,1.23918,0.680176,1.40022,0.839311,1.53196,1.08088,0.650785,0.719099,1.482,2.31884,1.91709,1.43673,0.861473,1.1391,0.996781,0.718046,0.941555,2.27909,0.653418,0.485304,0.293812,0.184289,1.27621,0.416214,0.838313,1.35996,0.87653,0.516549,0.63863,0.650472,1.49167,1.20739,1.09379,0.630949,0.993294,0.830321,0.459159,0.788782,0.280875
}}
}}

Revision as of 20:47, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr12:110843236..110843239,+p@chr12:110843236..110843239
+
Mm9::chr12:110853980..110853982,+p@chr12:110853980..110853982
+
Mm9::chr8:34525079..34525082,+p@chr8:34525079..34525082
+
Mm9::chr9:34353903..34353906,+p@chr9:34353903..34353906
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
nervous system2.47e-2275
central nervous system5.22e-2173
ectoderm-derived structure9.89e-1995
ectoderm9.89e-1995
presumptive ectoderm9.89e-1995
regional part of nervous system2.69e-1554
neurectoderm6.45e-1364
neural plate6.45e-1364
presumptive neural plate6.45e-1364
gray matter1.39e-1234
neural tube4.74e-1252
neural rod4.74e-1252
future spinal cord4.74e-1252
neural keel4.74e-1252
ecto-epithelium6.77e-1273
structure with developmental contribution from neural crest1.03e-0892
regional part of brain3.41e-0846
regional part of spinal cord4.53e-085
gray matter of spinal cord4.53e-085
basal ganglion6.67e-088
nuclear complex of neuraxis6.67e-088
aggregate regional part of brain6.67e-088
collection of basal ganglia6.67e-088
cerebral subcortex6.67e-088
brain6.94e-0847
future brain6.94e-0847
peripheral nervous system8.64e-0811
brain grey matter8.93e-0829
regional part of telencephalon8.93e-0829
telencephalon8.93e-0829
anterior neural tube1.08e-0740
regional part of forebrain4.15e-0739
forebrain4.15e-0739
future forebrain4.15e-0739


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}